Search for Novartis AG and
    1. 13 hours ago

      Novartis vows cost cuts after Swiss franc surge

      Novartis has leapt to the defence of the Swiss National Bank for removing the cap on the Swiss franc against the euro and...

    2. January 16, 2015

      Swiss surge could boost income investors

      UK investors who hold European and even UK equity income funds stand to benefit from the Swiss National Bank’s decision to...

    Special Reports

    1. Special Report: Boldness in Business 2012

      Seven success stories are honoured in this year’s awards...
    2. Combating Cancer

      A wave of drugs that harnesses the body’s immune system is fuelling optimism that scie...
    Search more Special Reports on this topic.

    1. January 15, 2015

      Swiss franc: Bern marks

      It is a rare tsunami that hits a landlocked nation in the mountains of Europe. So the metaphor is an odd choice to describe...

    2. January 9, 2015

      Small-cap Week, January 10

      Inhaler developer Vectura was among the biggest small-cap gainers this week, amid growing optimism over its royalty revenue....

    3. January 6, 2015

      FDA paves way for biosimilar drug approval

      The US pharmaceuticals watchdog has published a bullish assessment of a copycat biotech drug, paving the way for it to...

    4. December 28, 2014

      Malaria: Real and present danger

      Ka Lar Nar’s fellow east Myanmar villagers chuckle at the story of his periodic headaches because they know he likes his...

    5. December 17, 2014

      Juno Therapeutics vies for cancer treatment lead

      When Juno Therapeutics lists on Nasdaq on Friday, it will be one of the biggest events in a big year for the buoyant US...

    6. December 10, 2014

      Emphasis shifts from illness care to well care

      Spire, a small stone-like device less than the size of a walnut, clips on to your belt or bra quietly collecting information...

    7. December 10, 2014

      India assumes frontline position in battles over intellectual property rights

      As their cities grow more polluted, more people in India grapple with respiratory difficulties. The Swiss multinational...

    8. November 17, 2014

      GlaxoSmithKline leads Access to Medicine Index

      GlaxoSmithKline is leading the pharmaceuticals industry in efforts to widen global access to medicines, according to a...

    9. November 7, 2014

      UCB caps week of pharma dealmaking

      UCB of Belgium wrapped up another busy week of pharmaceuticals dealmaking on Friday with the $1.5bn disposal of its US...

    10. FT Alphaville

      October 29, 2014

      This is BABA, what's your target price? [updated]

      First on Alibaba, the FT reports that the Cayman registered derivative contract vaguely related to ecommerce in China — and...

    11. October 28, 2014

      Alibaba’s market value nudges Walmart

      Alibaba, the Chinese ecommerce behemoth that listed in New York last month, briefly muscled ahead of Walmart by one...

    12. October 22, 2014

      Witty riposte will only go some way to pacify drug group’s doubters

      Dull quarterly earnings statements with incremental numbers? Not for Sir Andrew Witty, chief executive of drugs giant...

    13. October 16, 2014

      Pharma giants face developing market ambitions

      As the pharmaceuticals industry careered towards the edge of its notorious patent cliff over the past decade, there was one...

    14. October 10, 2014

      Novartis strikes deal with Oxford BioMedica for cancer treatment

      Novartis will take a stake in Oxford BioMedica as part of a deal that will see the Swiss drugmaker work with the UK gene...

    15. September 26, 2014

      Drug development: Big pharma back in the game it made

      Big pharma is back. That, at least, is the impression created by a wave of new cancer drugs rapidly approaching market....

    16. July 29, 2014

      Time for business to experiment with wearables

      From digital wrist bands and smart watches to intelligent skin patches and head-mounted displays, this is the year of...

    17. July 28, 2014

      GSK and Reckitt: pharming out

      Well done Reckitt Benckiser and GlaxoSmithKline. But what took you so long? Both have recognised that pharmaceuticals and...

    18. July 23, 2014

      Longtime GSK favourite stumbles in the final furlong

      The Queen’s horse Estimate, former Gold Cup champion, has failed a drug test, as has GlaxoSmithKline. On Wednesday the group...

    19. July 18, 2014

      Technology: Wear your medicine

      Walter de Brouwer’s life changed when his son fell 35 feet from a window. Spending anxious months in intensive care, the...

    20. July 17, 2014

      Novartis maintains forecasts despite weak quarter

      Novartis confirmed its full-year profit and revenue forecasts, despite weaker than expected second-quarter results and the...

    21. July 15, 2014

      Big pharma teams up with big data

      Big pharma and Silicon Valley have been circling one another for some time, looking for ways in which they might harness the...

    22. July 15, 2014

      Google and Novartis to develop ‘smart’ contact lens for diabetics

      Google has struck a deal with Novartis to jointly develop “smart” contact lenses in the first alliance of its kind between...

    23. July 8, 2014

      AbbVie / Shire: debt and diversification

      The market does not think it will happen. AbbVie has upped its bid for Shire from £46.26 to £51.15 per share. In response,...

    24. July 1, 2014

      Novartis faces Japan charges over data manipulation by ex-staff

      Novartis is facing criminal charges in Japan over allegations that it failed to adequately oversee a former employee who...

    25. June 8, 2014

      Japanese drugmakers sit out global M&A party

      Japanese drugmakers have been conspicuous by their absence from the dealmaking bonanza sweeping the sector across Europe and...

    26. June 2, 2014

      GlaxoSmithKline in oncology push with $350m UK biotech deal

      GlaxoSmithKline has struck a deal potentially worth more than $350m to develop new cancer drugs with a UK biotech company,...

    27. May 30, 2014

      Hopes for cancer cures offer comfort for battered pharma

      It is the Holy Grail of medical science. Ever since Hippocrates, the Greek physician, first described the disease more than...

    28. May 29, 2014

      GlaxoSmithKline asks for bids on older drugs list

      GlaxoSmithKline has invited private equity firms to bid for some of its older drugs in the latest step by Sir Andrew Witty,...

    29. May 29, 2014

      Italian health ministry to seek €1.2bn from Roche and Novartis

      Italy’s health ministry said that it plans to seek damages of €1.2bn from Roche and Novartis after the Italian antitrust...

    30. FT Alphaville

      May 22, 2014

      London Value: Pet stocks for the long term

      We’re at the London Value Investing Conference, collecting tips from the value crowd. Tim Hatch of Brown Brothers Harriman...

    31. May 14, 2014

      GSK in China: when in doubt, do nothing

      Authorities in China say that GlaxoSmithKline’s Chinese subsidiary paid bribes on a massive scale and that the orders to do...

    32. May 1, 2014

      Boards, not comic book heroes

      You take your seat in the boardroom. The meeting is called to order. Directors size up the competition. And the chief...

    33. April 30, 2014

      GSK plays down prospect of white knight bid for AstraZeneca

      The chief executive of GlaxoSmithKline all but ruled out a white knight bid by the UK pharmaceuticals company for...

    34. April 25, 2014

      Race is on to find new treatments for malaria

      Mao Zedong may seem an unlikely hero of the battle against malaria. During his leadership of China in the 1960s,...

    35. April 24, 2014

      Zimmer agrees $13.4bn Biomet acquisition

      Zimmer, the maker of the eponymous walking frame, has agreed to acquire Biomet for $13.35bn, combining the two providers of...

    36. April 24, 2014

      Maul of the same growls on pay for Barclays’ Jenkins

      And lo, a day of judgment came upon “Saint” Antony Jenkins of the house of Barclays. He was cast among ravening lions – the...

    37. April 24, 2014

      Novartis profits boosted by sales in emerging markets

      Novartis posted a 23 per cent jump in net profits in the first quarter, thanks to the sale of one of its diagnostics units,...

    38. April 23, 2014

      The future of pharma lies in research, not cuts

      We have been presented this week with two visions for the future of innovation in the pharmaceuticals industry. One is...

    Search for Novartis AG and

    RELATED VIDEOS

    Videos from FT.com that closely match this topic

    1. Lex on potential conflict at Swiss drugs group...
      July 17, 2013

      Lex on potential conflict at Swiss drugs group

    2. Lex on Novartis' payment to its outgoing chairman...
      February 18, 2013

      Lex on Novartis' payment to its outgoing chairman